(Press-News.org) Contact information: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Not so dumb
Mysterious brain cells called microglia are starting to reveal their secrets thanks to research conducted at the Weizmann Institute of Science.
Until recently, most of the glory in brain research went to neurons. For more than a century, these electrically excitable cells were believed to perform the entirety of the information processing that makes the brain such an amazing machine. In contrast, cells called glia – which together account for about half of the brain's volume – were thought to be mere fillers that provided the neurons with support and protection but performed no vital function of their own. In fact, they had been named glia, the Greek for "glue," precisely because they were considered so unsophisticated.
But in the past few years, the glia cells – particularly the tiny microglia that make up about one-tenth of the brain cells – have been shown to play critical roles both in the healthy and in the diseased brain.
The octopi-like microglia are immune cells that conduct ongoing surveillance, swallowing cellular debris or, in the case of infection, microbes, to protect the brain from injury or disease. But these remarkable cells are more than cleaners: In the past few years, they have been found to be involved in shaping neuronal networks by pruning excessive synapses – the contact points that allow neurons to transmit signals – during embryonic development. They are probably also involved in reshaping the synapses as learning and memory occurs in the adult brain. Defects in microglia are believed to contribute to various neurological diseases, among them Alzheimer's disease and amyotrophic lateral sclerosis, or ALS. By clarifying how exactly the microglia operate on the molecular level, scientists might be able to develop new therapies for these disorders.
More than a decade ago, Weizmann Institute's Prof. Steffen Jung developed a transgenic mouse model that for the first time enabled scientists to visualize the highly active microglia in the live brain. Now Jung has made a crucial next step: His laboratory developed a system for investigating the functions of microglia.
The scientists have equipped mice with a genetic switch: an enzyme that can rearrange previously marked portions of the DNA. The switch is activated by a drug: When the mouse receives the drug, the enzyme performs a genetic manipulation – for example, to disable a particular gene. The switch is so designed that over the long term, it targets only the microglia, but not other cells in the brain or in the rest of the organism. In this manner, researchers can clarify not only the function of the microglia, but the roles of different genes in their mechanism of action.
As reported in Nature Neuroscience, Weizmann scientists, in collaboration with the team of Prof. Marco Prinz at the University of Freiburg, Germany, recently used this system to examine the role of an inflammatory gene expressed by the microglia. They found that the microglia contribute to an animal disease equivalent of multiple sclerosis. Prof. Jung's team
included Yochai Wolf, Diana Varol and Dr. Simon Yona, all of Weizmann's Immunology Department.
The system developed at the Weizmann Institute, currently applied in numerous other studies by researchers at Weizmann and elsewhere, promises to shed new light on the role of the microglia in the healthy brain as well as in Alzheimer's, ALS and various other diseases.
Prof. Steffen Jung's research is supported by the Leir Charitable Foundations; the Leona M. and Harry B. Helmsley Charitable Trust; the Adelis Foundation; Lord David Alliance, CBE; the Wolfson Family Charitable Trust; the estate of Olga Klein Astrachan; and the European Research Council.
The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.
INFORMATION:
Weizmann Institute news releases are posted on the World Wide Web at
http://wis-wander.weizmann.ac.il, and are also available at http://www.eurekalert.org.
Not so dumb
2013-11-25
ELSE PRESS RELEASES FROM THIS DATE:
Super SQUID
2013-11-25
Super SQUID
Weizmann Institute scientists have taken a quantum leap toward understanding the phenomenon known as superconductivity: They have created the world's smallest SQUID – a device used to measure magnetic fields – which has broken the world record ...
The reality behind Europe's response to climate change
2013-11-25
The reality behind Europe's response to climate change
1 in every 3 European cities studied have no plans yet to reduce greenhouse gas emissions
British cities – unlike their counterparts on the mainland - are taking the lead in making plans to curb and handle the impact ...
Customized palliative care models improve care and reduce health care costs
2013-11-25
Customized palliative care models improve care and reduce health care costs
New Rochelle, NY, November 25, 2013—For high-risk geriatric patients, improved palliative care that is matched to their changing needs at home can ...
Co-transplanted cells and treadmill training aids rats with spinal cord injury
2013-11-25
Co-transplanted cells and treadmill training aids rats with spinal cord injury
Putnam Valley, NY. (Nov. 25 2013) – After Schwann cells (SCs), the principal cells in the peripheral nervous system, and olfactory ensheathing cells (OECs), ...
'Rare' gene is common in african descendants and may contribute to risk of heart disease
2013-11-25
'Rare' gene is common in african descendants and may contribute to risk of heart disease
The gene can increase levels of triglyceride fats in blood, which may contribute to risk of heart disease and other disorders
NEW YORK (November 25, 2013) ...
EPC secreted factors favorably impact on pancreatic islet cell cotransplantation
2013-11-25
EPC secreted factors favorably impact on pancreatic islet cell cotransplantation
Putnam Valley, NY. (Nov. 25 2013) – Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted ...
Graphic warnings labels on cigarette packs could lead to 8.6 million fewer smokers in the US
2013-11-25
Graphic warnings labels on cigarette packs could lead to 8.6 million fewer smokers in the US
New international study suggests that recent US court decisions on graphic warnings were based upon a model that under-estimated the potential impact on smoking rates
A ...
A step closer to composite-based electronics
2013-11-25
A step closer to composite-based electronics
A new study demonstrates that electrical resistivity obeys a staircase-like dependence on the conducting particle concentration in composite materials
Composite materials are of increasing interest to physicists. Typically, ...
Rice scientists ID new catalyst for cleanup of nitrites
2013-11-25
Rice scientists ID new catalyst for cleanup of nitrites
Gold-palladium nanocatalysts set new mark for breakdown of nitrites
HOUSTON -- (Nov. 25, 2013) -- Chemical engineers at Rice University have found a new catalyst that can rapidly break down nitrites, a common and harmful ...
Common brain cell plays key role in shaping neural circuits, Stanford study finds
2013-11-25
Common brain cell plays key role in shaping neural circuits, Stanford study finds
STANFORD, Calif. — Stanford University School of Medicine neuroscientists have discovered a new role played by a common but mysterious class of brain cells.
Their ...